246 related articles for article (PubMed ID: 23891296)
1. Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors.
Denecke T; Baur AD; Ihm C; Steffen IG; Tischer E; Arsenic R; Pascher A; Wiedenmann B; Pavel M
Eur J Radiol; 2013 Oct; 82(10):e550-5. PubMed ID: 23891296
[TBL] [Abstract][Full Text] [Related]
2. Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade.
Kim JH; Eun HW; Kim YJ; Han JK; Choi BI
Abdom Imaging; 2013 Oct; 38(5):1106-14. PubMed ID: 23728305
[TBL] [Abstract][Full Text] [Related]
3. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
[TBL] [Abstract][Full Text] [Related]
4. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
[TBL] [Abstract][Full Text] [Related]
5. The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases.
Han X; Zhang C; Tang M; Xu X; Liu L; Ji Y; Pan B; Lou W
Eur J Gastroenterol Hepatol; 2015 May; 27(5):527-35. PubMed ID: 25822862
[TBL] [Abstract][Full Text] [Related]
6. [Imaging of neuroendocrine tumors].
Gualdi GF; Casciani E; Polettini E
Clin Ter; 2001; 152(2):107-21. PubMed ID: 11441522
[TBL] [Abstract][Full Text] [Related]
7. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.
Nikou GC; Marinou K; Thomakos P; Papageorgiou D; Sanzanidis V; Nikolaou P; Kosmidis C; Moulakakis A; Mallas E
Pancreatology; 2008; 8(4-5):510-9. PubMed ID: 18765956
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic neuroendocrine neoplasms.
Hörsch D; Bert T; Schrader J; Hommann M; Kaemmerer D; Petrovitch A; Zaknun J; Baum RP
Minerva Gastroenterol Dietol; 2012 Dec; 58(4):401-26. PubMed ID: 23207615
[TBL] [Abstract][Full Text] [Related]
10. Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy.
Ćwikła JB; Bodei L; Kolasinska-Ćwikła A; Sankowski A; Modlin IM; Kidd M
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1437-45. PubMed ID: 26348352
[TBL] [Abstract][Full Text] [Related]
11. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
Yang Z; Tang LH; Klimstra DS
Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT.
Sofue K; Tateishi U; Tsurusaki M; Arai Y; Yamazaki N; Sugimura K
Eur J Radiol; 2012 Apr; 81(4):714-8. PubMed ID: 21353412
[TBL] [Abstract][Full Text] [Related]
13. Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.
Kondo NI; Ikeda Y; Maehara S; Sugimoto R; Nishiyama K; Sakaguchi Y
JOP; 2013 Jul; 14(4):415-22. PubMed ID: 23846939
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography.
Yamada S; Fujii T; Suzuki K; Inokawa Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Pancreas; 2016 Feb; 45(2):198-203. PubMed ID: 26390421
[TBL] [Abstract][Full Text] [Related]
15. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E
J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes and prognostic factors of transcatheter arterial chemoembolization for hepatic neuroendocrine metastases.
Hur S; Chung JW; Kim HC; Oh DY; Lee SH; Bang YJ; Kim WH
J Vasc Interv Radiol; 2013 Jul; 24(7):947-56; quiz 957. PubMed ID: 23602421
[TBL] [Abstract][Full Text] [Related]
17. Management of pancreatic neuroendocrine tumors.
Dickson PV; Behrman SW
Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumours.
Alexakis N; Neoptolemos JP
Best Pract Res Clin Gastroenterol; 2008; 22(1):183-205. PubMed ID: 18206821
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.
De Robertis R; Cingarlini S; Tinazzi Martini P; Ortolani S; Butturini G; Landoni L; Regi P; Girelli R; Capelli P; Gobbo S; Tortora G; Scarpa A; Pederzoli P; D'Onofrio M
World J Gastroenterol; 2017 Jan; 23(2):275-285. PubMed ID: 28127201
[TBL] [Abstract][Full Text] [Related]
20. Dull abdominal pain caused by non-functional metastatic neuroendocrine tumor.
Michael L; Arazi-Kleinman T; Yosepovich A; Bar-Meir S
Isr Med Assoc J; 2006 Oct; 8(10):716-7. PubMed ID: 17125124
[No Abstract] [Full Text] [Related]
[Next] [New Search]
